Optimism Eye Medicine: The first subject has been enrolled in the Phase II clinical trial of Fouvizantongzuo Eye Drops.

Xingqi Eye Medicine Announcement: The company's research and development of Voriconazole Eye Drops completed the first subject enrollment today, officially entering Phase II clinical trials. The Phase II clinical trial of Voriconazole Eye Drops is a randomized, positive control, multicenter exploratory trial, aiming to preliminarily explore the effectiveness and safety of Voriconazole Eye Drops in subjects with fungal keratitis, and explore safe and effective drug concentrations for Phase III clinical trials.